Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 591 of 5804
-
Stem cells injected into heart could ease failure
Disease control OngoingThis clinical study will utilize allogenic bone marrow-derived culture-expanded MSC that are expanded from mesenchymal stem cells and delivered using the investigational Helix transendocardial delivery catheter as a therapy for ischemic HFrEF with reduced ejection fraction.
Phase: PHASE1, PHASE2 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Anti-aging pill tested in 1-year human trial
Disease control Recruiting nowThis study is a single-center, randomized, double-blind, placebo-controlled clinical trial investigating a pharmacological intervention for aging. Its primary objective is to evaluate the efficacy of NMN while ensuring the safety of oral administration, with the aim of identifyin…
Phase: NA • Sponsor: People's Hospital of Quzhou • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo offers hope for kidney cancer patients who stopped responding to immunotherapy
Disease control OngoingThis is a phase II, open-label, multicenter, single-arm study evaluating the efficacy and safety of cadonilimab (AK104) in combination with lenvatinib in patients with unresectable advanced or metastatic clear cell renal cell carcinoma (ccRCC) who experienced disease progression …
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a natural compound help seniors survive sepsis?
Disease control Recruiting nowThe long-term goal is to test the clinical efficacy of senolytic therapies to reduce progression to and severity of sepsis in older patients. The central hypothesis is that a threshold burden of SnCs predisposes to a SASP mediated dysfunctional response to PAMPs, contributing to …
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New combo aims to clear hepatitis b virus in 86-Patient trial
Disease control OngoingThis study will evaluate the efficacy and safety of PEG-IFNα alone or in combination with different dose levels of BRII-835 (VIR-2218) in participants with chronic hepatitis B virus (HBV) infection.
Phase: PHASE2 • Sponsor: Brii Biosciences Limited • Aim: Disease control
Last updated Jun 26, 2026 13:27 UTC
-
New drug shows promise for rare overgrowth conditions
Disease control Recruiting nowThis study is a multi-center, open-label, single arm, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of CYH33 in patients with PIK3CA-related overgrowth spectrum (PROS) and PIK3CA-related vascular malformations (PRVM)
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New diabetes drug tirzepatide tested in chinese patients
Disease control CompletedThe main purpose of this study is to investigate the efficacy and safety of Tirzepatide monotherapy in Chinese participants with Type 2 Diabetes.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Old drug, new trick: colchicine may shield hearts during surgery
Disease control Recruiting nowHeart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, strok…
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
DNA vaccine trains immune system to fight brain cancer
Disease control CompletedThis Phase I clinical trial will evaluate the safety, tolerability, immunogenicity, and preliminary efficacy of 8 mg ITI-1001 in participants with newly diagnosed glioblastoma (GBM).
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Cannabis chemicals join fight against deadly brain tumor
Disease control CompletedGlioblastoma is the primary brain tumour with the worst prognosis: median survival is only 12 months despite the use of the most advanced treatments. In the past 10 years, survival in the treatment of this disease has not advanced significantly, with the postoperative standard be…
Phase: PHASE1, PHASE2 • Sponsor: Grupo Español de Investigación en Neurooncología • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a simple infusion save transplanted kidneys from a stealthy virus?
Disease control Recruiting nowBEAT-BK will see the effect of immunosuppression reduction/modification with and without IVIG on BKPyV infection, allograft function, allograft loss, acute transplant rejection, immunosuppression load and death in kidney and simultaneous kidney pancreas transplant recipients with…
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a Nutrient-Packed supplement boost baby brain development and prevent early birth?
Disease control OngoingThe goal of this clinical trial is to test (1) a novel maternal ready-to-use supplementary food and (2) a novel cognitive behavioral therapy intervention in undernourished Sierra Leonean women. The main questions it aims to answer are: * Will the addition of omega-3 long-chain p…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug cocktail aims to outsmart ALK lung cancer
Disease control Recruiting nowThis study will test the safety of the combination of ramucirumab and lorlatinib. The researchers will test one or two different doses of lorlatinib in combination with ramucirumab to find the drug combination dose that causes few or mild side effects in participants. Once the re…
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug hope for rare kidney disease: daratumumab trial launches
Disease control Recruiting nowThe purpose of this research is to study the safety and efficacy of daratumumab in inducing complete or partial remission in people with proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID).
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 26, 2026 18:10 UTC
-
New combo aims to keep High-Risk myeloma at bay after transplant
Disease control Recruiting nowTo learn if isatuximab can help to control highrisk MM when given in combination with lenalidomide after an autologous stem cell transplantation (ASCT).
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New cream could help men regrow hair – phase 3 trial complete
Disease control CompletedThe purpose of the study is to see if Clascoterone can help people with male pattern hair loss to recovery and see if the treatment is effective and safe and how well the drug is tolerated by subjects. Within this study, the Clascoterone solution will be compared to a placebo. …
Phase: PHASE3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Simple combo could stop hepatitis b passed from mom to baby
Prevention CompletedThis is a double-blind, randomized placebo-controlled trial (RCT) of a prophylaxis-for-all approach to prevention of mother-to-child transmission (PMTCT) of hepatitis B virus (HBV) in the Democratic Republic of Congo (DRC). HBV-infected pregnant women will be randomized to either…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
AI-Powered pulse check could spot hidden heart defects in newborns
Diagnosis Recruiting nowThe purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.
Phase: NA • Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to stop BRAF colon cancer in its tracks
Disease control OngoingThis phase II/III trial compares the effect of the combination of encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafen…
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a dopamine-blocking drug safely control tourette syndrome over years?
Disease control OngoingThe primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tour…
Phase: PHASE3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC